Results

eNauka >  Rezultati >  JAK2-mutant hematopoietic cells display metabolic alterations that can be targeted to treat myeloproliferative neoplasms
Naziv: JAK2-mutant hematopoietic cells display metabolic alterations that can be targeted to treat myeloproliferative neoplasms
Autori: Rao, Tata Nageswara; Hansen, Nils; Hilfiker, Julian; Rai, Shivam; Majewska, Julia-Magdalena; Leković, Danijela  ; Gezer, Deniz; Andina, Nicola; Galli, Serena; Cassel, Teresa;
Godina: 2019
Publikacija: Blood
ISSN: 0006-4971 Blood Pretraži identifikator
Izdavač: Amer Soc Hematology, Washington
Tip rezultata: Naučni članak
Kolacija: vol. 134 br. 21 str. 1832-1846
DOI: 10.1182/blood.2019000162
WoS-ID: 000499645800010
Scopus-ID: 2-s2.0-85074985153
PMID: 31511238
URI: http://rimi.imi.bg.ac.rs/handle/123456789/919
https://enauka.gov.rs/handle/123456789/415344
Projekat: Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission [31003A-147016/1, 31003A_166613]
SystemsX.ch (Medical Research and Development Grant) [2014/266]
Swiss Cancer League [KLS-2950-02-2012, KFS-3655-02-2015]
Forschungsfonds der Universitat Basel [DMM 2039]
Krebsliga Beider Basel [KLbB-4486]
Resource Facility for Stable Isotope Resolved Metabolomics - National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [1U24DK097215-01A1]
Markey Cancer Center grant [P30CA177558]
United States Department of Health & Human Services, National Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30CA177558, P30CA177558, P30CA177558, P30CA177558, P30CA177558, P30CA177558, P30CA177558, P30CA17755]
United States Department of Health & Human Services, National Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [U24DK097215, U24DK097215]
M-kategorija: 
21a+M21a+ - Vodeći međunarodni časopis kategorije M21a+

61
SCOPUSTM
52
PubMed CentralTM
30
OpenCitations
62
WEB OF SCIENCETM
Altmetric
Dimensions
Unpaywall

Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.